전남대학교 세포재생연구센터

• 442
• Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
• 2024

• 441
• COVID-19 Vaccination-Related Pericarditis: A Korean Nationwide Study
• 2024

• 440
• IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage-myofibroblast transition
• 2024

• 439
• Long-Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study
• 2024

• 438
• Risk of Bleeding and Ischemia in Elderly East Asian Patients with Diabetes Mellitus Treated with either Clopidogrel or Ticagrelor: From the Korean Acute Myocardial Infarction Registry-V60
• 2024

• 437
• Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics-Related Cardiac Dysfunction
• 2024

• 436
• Pre-Hospital Delay and Outcomes in Myocardial Infarction With Nonobstructive Coronary Arteries
• 2024

• 435
• Ten-year trends in lipid management among patients after myocardial infarction in South Korea
• 2024

• 434
• Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction
• 2024

• 433
• Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment
• 2024